| Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) S Moe, T Drüeke, J Cunningham, W Goodman, K Martin, K Olgaard, S Ott, ... Kidney international 69 (11), 1945-1953, 2006 | 2221 | 2006 |
| Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis GA Block, KJ Martin, ALM De Francisco, SA Turner, MM Avram, ... New England Journal of Medicine 350 (15), 1516-1525, 2004 | 1408 | 2004 |
| Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters M Ketteler, GA Block, P Evenepoel, M Fukagawa, CA Herzog, L McCann, ... Kidney international 92 (1), 26-36, 2017 | 1000 | 2017 |
| Pathophysiology of vascular calcification in chronic kidney disease SM Moe, NX Chen Circulation research 95 (6), 560-567, 2004 | 699 | 2004 |
| Mechanisms of vascular calcification in chronic kidney disease SM Moe, NX Chen Journal of the American Society of Nephrology 19 (2), 213-216, 2008 | 659 | 2008 |
| Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins SM Moe, KD O'Neill, D Duan, S Ahmed, NX Chen, SB Leapman, ... Kidney international 61 (2), 638-647, 2002 | 623 | 2002 |
| Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease SM Moe, MP Zidehsarai, MA Chambers, LA Jackman, JS Radcliffe, ... Clinical Journal of the American Society of Nephrology 6 (2), 257-264, 2011 | 612 | 2011 |
| Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD) SM Moe, M Reslerova, M Ketteler, K O'neill, D Duan, J Koczman, ... Kidney international 67 (6), 2295-2304, 2005 | 518 | 2005 |
| Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States RE LaClair, RN Hellman, SL Karp, M Kraus, S Ofner, Q Li, KL Graves, ... American Journal of Kidney Diseases 45 (6), 1026-1033, 2005 | 502 | 2005 |
| Disorders involving calcium, phosphorus, and magnesium SM Moe Primary Care: Clinics in Office Practice 35 (2), 215-237, 2008 | 501 | 2008 |
| Achieving NKF-K/DOQI™ bone metabolism and disease treatment goals with cinacalcet HCl SM Moe, GM Chertow, JW Coburn, LD Quarles, WG Goodman, GA Block, ... Kidney international 67 (2), 760-771, 2005 | 450 | 2005 |
| Kidney disease: improving global outcomes (KDIGO). Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving … S Moe Kidney Int 69, 1945-1953, 2006 | 447 | 2006 |
| Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells NX Chen, KD O'Neill, D Duan, SM Moe Kidney international 62 (5), 1724-1731, 2002 | 447 | 2002 |
| Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels SM Moe, D Duan, BP Doehle, KD O'Neill, NX Chen Kidney international 63 (3), 1003-1011, 2003 | 440 | 2003 |
| Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney And … FC Brosius III, TH Hostetter, E Kelepouris, MM Mitsnefes, SM Moe, ... Circulation 114 (10), 1083-1087, 2006 | 432 | 2006 |
| Chronic kidney disease–mineral-bone disorder: a new paradigm SM Moe, T Drüeke, N Lameire, G Eknoyan Advances in chronic kidney disease 14 (1), 3-12, 2007 | 345 | 2007 |
| Diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder: Synopsis of the kidney disease: improving global outcomes 2017 clinical … M Ketteler, GA Block, P Evenepoel, M Fukagawa, CA Herzog, L McCann, ... Annals of internal medicine 168 (6), 422-430, 2018 | 344 | 2018 |
| Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: the evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial SM Moe, GM Chertow, PS Parfrey, Y Kubo, GA Block, R Correa-Rotter, ... Circulation 132 (1), 27-39, 2015 | 303 | 2015 |
| Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells S Ahmed, AF Hood, AP Evan, SM Moe American journal of kidney diseases 37 (6), 1267-1276, 2001 | 303 | 2001 |
| Oral calcium carbonate affects calcium but not phosphorus balance in stage 3–4 chronic kidney disease KM Hill, BR Martin, ME Wastney, GP McCabe, SM Moe, CM Weaver, ... Kidney international 83 (5), 959-966, 2013 | 297 | 2013 |
